Feroz and Ansari, 2023

medicine
Author

Feroz and Ansari

Year of Publication

2023

Journal

Archives of Clinical Psychiatry

ISSN

1806-938X

Publisher

Faculdade de Medicina, Universidade de São Paulo (São Paulo, Brazil)

Indexing

Embase, Web of Science, Scopus (discontinued)

TMS is a depression therapy that has been approved by regulatory bodies like the U.S. Food and Drug Administration (FDA) as of my most recent update in September 2021, and it is accessible in many nations across the world. For the most up-to-date information about TMS, it is best to speak with a medical expert or examine more current sources as medical developments could have taken place after this time.1

References

1Feroz H, Ansari MJ. A comparative study of cognitive behavioral therapy and transcranial magnetic stimulation for obsessive compulsive disorder. Archives of Clinical Psychiatry. 2023;50(4). Accessed April 19, 2025. https://archivespsy.com/menu-script/index.php/ACF/article/view/2161